NCT02668029
- Conditions
- Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
- Locations
-
Not specified
Clinical trial condition
Pulmonary Fibrosis
Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.
130 public trials
24 recruiting studies
Pulmonary Fibrosis trial results
NCT00786201
- Conditions
- Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Miami, Florida, United States
- Tampa, Florida, United States
NCT00517933
- Conditions
- Cardiovascular Diseases, Fibrosis, Hypertension, +9 more
- Locations
-
- University of Alabama - Birmingham Birmingham, Alabama, United States
- University of California - Los Angeles Los Angeles, California, United States
- University of California - San Francisco San Francisco, California, United States
- National Jewish Medical and Research Center Denver, Colorado, United States
Completed
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
NCT00650091
- Conditions
- Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
- Locations
-
- University of Alabama - Birmingham Birmingham, Alabama, United States
- University of California - Los Angeles Los Angeles, California, United States
- University of California - San Francisco San Francisco, California, United States
- National Jewish Medical and Research Center Denver, Colorado, United States
Completed
Scleroderma Lung Disease
NCT00004563
- Conditions
- Connective Tissue Diseases, Fibrosis, Lung Diseases, +9 more
- Locations
-
Not specified
Completed
Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
NCT00639496
- Conditions
- Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
- Locations
-
- U.Z. Ghent Ghent, Belgium
- Hôpital A. Calmette Lille, France
- Klinikum Grosshadern Munich, Germany
- U.O. di Pneumologia-Ospedale Arezzo, Italy
NCT00514683
- Conditions
- Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
- Locations
-
- 1199.30.54002 Boehringer Ingelheim Investigational Site Mendoza, Argentina
- 1199.30.61005 Boehringer Ingelheim Investigational Site South Brisbane, Queensland, Australia
- 1199.30.61003 Boehringer Ingelheim Investigational Site Toorak Gardens, South Australia, Australia
- 1199.30.61004 Boehringer Ingelheim Investigational Site Woodville, South Australia, Australia
NCT01825538
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +9 more
- Locations
-
- The Ohio State University Wexner Medical Center Columbus, Ohio, United States
NCT00504621
- Conditions
- Fatigue, Fibrosis, Hemic and Lymphatic Diseases, +13 more
- Locations
-
Not specified
Completed
Diffuse Fibrotic Lung Disease
NCT00000596
- Conditions
- Fibrosis, Hemic and Lymphatic Diseases, Hypersensitivity, +11 more
- Locations
-
Not specified